Abstract
A longitudinal prospective study was undertook to investigate the effect of multifactorial target control, recommended by the American Diabetes Association (ADA), on macrovascular disease in patients with short-duration type 2 diabetes. Patients who were newly diagnosed with type 2 diabetes or within 1 year and had no previous vascular diseases or atherosclerosis plaques were enrolled in the present study. All patients received multifactorial intervention, with pharmacologic therapy targeting hyperglycemia, hypertension, dyslipidemia, along with secondary prevention of vascular disease with aspirin when necessary according to the ADA recommendation. Patients were followed up for 8 years (2002–2010). The ultrasounds of arteries (carotid, iliac and femoral arteries) were measured every year. The primary endpoint was the time to the first occurrence of atherosclerosis plaques of the arteries. The second endpoint was clinical evidence of cardiovascular diseases. One hundred and forty-three patients were recruited, and the mean age was 50 (6.92) years. During the study, atherosclerosis plaques occurred in 49 patients. Systolic blood pressure less than 130 mmHg [hazard ratio (HR), 0.236; 95 % confidence interval (CI) 0.076–0.734; P = 0.013] and fasting plasma glucose less than 7 mmol/l (HR, 0.457; 95 % CI 0.210–0.994; P = 0.048) were significantly associated with decreased onset of atherosclerosis plaques. Simultaneous target control of systolic blood pressure and fasting plasma glucose reduced the risk of atherosclerosis plaques by 18 % (P = 0.097) and cardiovascular diseases by 16 % (P = 0.046). Multifactorial target treatment in patients with short-duration type 2 diabetes can effectively reduce the risk of macrovascular complications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
K.S. Taylor, C.J. Heneghan, A.J. Farmer, A.M. Fuller, A.I. Adler, J.K. Aronson and R.J. Stevens, All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large UK primary care database. Diabetes Care (2013)
M. Woodward, X. Zhang, F. Barzi, W. Pan, H. Ueshima, A. Rodgers, S. MacMahon, The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 26, 360–366 (2003)
V. Perkovic, H.L. Heerspink, J. Chalmers, M. Woodward, M. Jun, Q. Li, S. MacMahon, M.E. Cooper, P. Hamet, M. Marre, C.E. Mogensen, N. Poulter, G. Mancia, A. Cass, A. Patel, S. Zoungas, Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int. 83, 517–523 (2013)
I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E. Manley, C.A. Cull, D. Hadden, R.C. Turner, R.R. Holman, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405–412 (2000)
H.C. Gerstein, M.E. Miller, R.P. Byington, D.J. Goff, J.T. Bigger, J.B. Buse, W.C. Cushman, S. Genuth, F. Ismail-Beigi, R.J. Grimm, J.L. Probstfield, D.G. Simons-Morton, W.T. Friedewald, Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545–2559 (2008)
W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, P.D. Reaven, F.J. Zieve, J. Marks, S.N. Davis, R. Hayward, S.R. Warren, S. Goldman, M. McCarren, M.E. Vitek, W.G. Henderson, G.D. Huang, Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129–139 (2009)
P. Gaede, P. Vedel, N. Larsen, G.V. Jensen, H.H. Parving, O. Pedersen, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348, 383–393 (2003)
J.F. Polak, M. Szklo, R.A. Kronmal, G.L. Burke, S. Shea, A.E. Zavodni, D.H. O’Leary, The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J. Am. Heart Assoc. 2, e000087 (2013)
L. Li, H. Yu, J. Zhu, X. Wu, F. Liu, F. Zhang, Q. Li, S. Wu, Y. Bao, W. Jia, The combination of carotid and lower extremity ultrasonography increases the detection of atherosclerosis in type 2 diabetes patients. J. Diabetes Complicat. 26, 23–28 (2012)
M.K. Kramer, J.R. McWilliams, H.Y. Chen, L.M. Siminerio, A community-based diabetes prevention program: evaluation of the group lifestyle balance program delivered by diabetes educators. Diabetes Educ. 37, 659–668 (2011)
M. Dehghan, A. Mente, K.K. Teo, P. Gao, P. Sleight, G. Dagenais, A. Avezum, J.L. Probstfield, T. Dans, S. Yusuf, Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation 126, 2705–2712 (2012)
P. Jha, C. Ramasundarahettige, V. Landsman, B. Rostron, M. Thun, R.N. Anderson, T. McAfee, R. Peto, 21st-century hazards of smoking and benefits of cessation in the United States. N. Engl. J. Med. 368, 341–350 (2013)
C. Clair, N.A. Rigotti, B. Porneala, C.S. Fox, R.B. D’Agostino, M.J. Pencina, J.B. Meigs, Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 309, 1014–1021 (2013)
E.W. Gregg, H. Chen, L.E. Wagenknecht, J.M. Clark, L.M. Delahanty, J. Bantle, H.J. Pownall, K.C. Johnson, M.M. Safford, A.E. Kitabchi, F.X. Pi-Sunyer, R.R. Wing, A.G. Bertoni, Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308, 2489–2496 (2012)
R.C. Turner et al., Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837–853 (1998)
W.L. Lee, A.M. Cheung, D. Cape, B. Zinman, Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23, 962–968 (2000)
G.L. Booth, M.K. Kapral, K. Fung, J.V. Tu, Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368, 29–36 (2006)
A.I. Adler, I.M. Stratton, H.A. Neil, J.S. Yudkin, D.R. Matthews, C.A. Cull, A.D. Wright, R.C. Turner, R.R. Holman, Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321, 412–419 (2000)
I.M. Stratton, C.A. Cull, A.I. Adler, D.R. Matthews, H.A. Neil, R.R. Holman, Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 49, 1761–1769 (2006)
S. Zoungas, B.E. de Galan, T. Ninomiya, D. Grobbee, P. Hamet, S. Heller, S. MacMahon, M. Marre, B. Neal, A. Patel, M. Woodward, J. Chalmers, A. Cass, P. Glasziou, S. Harrap, L. Lisheng, G. Mancia, A. Pillai, N. Poulter, V. Perkovic, F. Travert, Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care 32, 2068–2074 (2009)
S.J. Griffin, K. Borch-Johnsen, M.J. Davies, K. Khunti, G.E. Rutten, A. Sandbaek, S.J. Sharp, R.K. Simmons, M. van den Donk, N.J. Wareham, T. Lauritzen, Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 378, 156–167 (2011)
P.M. Kearney, L. Blackwell, R. Collins, A. Keech, J. Simes, R. Peto, J. Armitage, C. Baigent, Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371, 117–125 (2008)
B. Mihaylova, J. Emberson, L. Blackwell, A. Keech, J. Simes, E.H. Barnes, M. Voysey, A. Gray, R. Collins, C. Baigent, The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380, 581–590 (2012)
Acknowledgments
This study was supported by funds from the National Key Research Project for the Tenth Five-Year Plan (2001BA702B01), the National Key Research Project for the Eleventh Five-Year Plan (2006BAI02B08). None of the authors have any conflicts of interest to declare. W.-x.W. and M.R. contributed to the data analysis and draft writing. H.C., L. Y. and C.Y. contributed to the critical revision of the article for important intellectual content. Y.-q.Q performed the measurement of clinical and biochemical characteristics. Y.L. provided the suggestions on the study design and draft revision. H.C. and L.Y. contributed to the study conception and design. The present study would not have been possible without the participants. L.Y. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of interest
All authors of this manuscript have read and approved to submit the manuscript to your journal in its current form. None of the authors have any conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Wen-Xia Wu and Meng Ren have contributed equally to this study.
Rights and permissions
About this article
Cite this article
Wu, Wx., Ren, M., Cheng, H. et al. Prevention of macrovascular disease in patients with short-duration type 2 diabetes by multifactorial target control: an 8-year prospective study. Endocrine 47, 485–492 (2014). https://doi.org/10.1007/s12020-013-0158-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0158-x